Download Free Medical Hemodialysis And Peritoneal Dialysis PowerPoint Presentation

Hemodialysis And Peritoneal Dialysis PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "Hemodialysis and Peritoneal Dialysis”.

This medical PowerPoint presentation is about hemodialysis and peritoneal dialysis, both types of renal replacement therapy used to treat end-stage renal disease (ESRD), a condition where the kidneys have lost the ability to filter waste and excess fluid from the blood. Both procedures involve the use of a machine to remove waste and excess fluid from the body, but they differ in how they accomplish this task.

Hemodialysis-Hemodialysis is a type of dialysis that uses an external machine to filter blood. During hemodialysis, blood is removed from the patients body and passed through a dialysis machine where it is cleaned and filtered before being returned to the patient. The procedure typically takes 3-4 hours and is usually performed in a hospital or dialysis center three times per week.

Peritoneal dialysis-Peritoneal dialysis is a type of dialysis that uses the patients own abdominal lining (peritoneum) to filter waste and excess fluid from the blood. A sterile solution called dialysate is introduced into the patients abdomen through a catheter, and the peritoneum acts as a natural filter, allowing waste and excess fluid to pass from the blood into the dialysate. After several hours, the dialysate is drained from the patients abdomen, taking the waste and excess fluid with it. This procedure can be performed at home or work, and is usually done 4-6 times per day.

Tags : renal replacement therapy, end-stage renal disease, kidneys, Hemodialysis, Peritoneal dialysis, Nephrology, Nephrology PowerPoint presentation

Published on : Jun 07, 2023 | Views : 3027 | Downloads : 14

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Hemodialysis and Peritoneal Dialysis
Slide 2-

Objectives Understand functioning of peritoneal dialysis and haemodialysis List and understand infection-associated risks for PD and HD from specific organisms/specific procedures Understand and be able to design infection prevention and control measures for PD and HD patients August 16, 2013 2
Slide 3-

Time involved 50 minutes August 16, 2013 3
Slide 4-

Key points Dialysis patients are at high risk of infection Due to underlying illness and other environmental and procedural factors A comprehensive infection prevention and control program for dialysis settings reduces infection risk for patients and staff The patient plays an important part in prevention and requires education August 16, 2013 4
Slide 5-

Background Healthy kidneys clean blood and remove bodily fluids by producing urine Patients who require dialysis have an increased risk of infection due to: Prolonged vascular access or methods used for dialysis Immunosuppression from end stage renal disease Co-morbid conditions such as diabetes August 16, 2013 5
Slide 6-

Peritoneal dialysis (PD) Instillation of dialysis fluids into the peritoneal space via a surgically-inserted catheter Most catheters are silicone Fluid is removed to take out toxins Most common types include: Chronic ambulatory Continuous cyclical Chronic intermittent August 16, 2013 6
Slide 7-

Peritoneal Dialysis August 16, 2013 7
Slide 8-

Potential Adverse Events Peritonitis Due to contamination at time of exchange or infection of the exit site Loss of access site Due to infection and fibrosis Death If sepsis develops August 16, 2013 8
Slide 9-

Haemodialysis (HD) Dialysis machine and a dialyser clean the blood Blood and dialysis fluids do not mix Can take up to 3-6 hours Usually 3 times per week Either inpatient or outpatient by trained staff August 16, 2013 9
Slide 10-

Haemodialysis August 16, 2013 10
Slide 11-

Definitions - 1 Central catheter: Highest risk of infection For short term access use for HD Standard catheter care procedures must be followed Fistula: Lowest risk of infection A surgically-created connection between an artery and vein (usually in the arm) Accessed via for needle for HD. August 16, 2013 11
Slide 12-

Definitions - 2 Vascular graft: Intermediate risk of infection A surgically placed artificial tube between a vein and artery (usually in the arm). Accessed via needle for HD Dialysate: A balanced electrolyte solution on one side of the semi-permeable membrane to exchange solutes with blood during HD Dialysis water: Purified water that is used to: mix dialysate to disinfect, rinse, or reprocess the dialyser August 16, 2013 12
Slide 13-

Definitions - 3 Dialyser: Part of the HD machine Two sections separated by a membrane Patient’s blood flows through one side and dialysate flows through the other August 16, 2013 13
Slide 14-

Definitions - 4 Hepatitis B virus HBsAg Hepatitis B surface antigen All HBsAg patients are infectious and may transmit Hepatitis B HBeAg Hepatitis B „e” antigen is a part of the virus that enters the blood in patients with active infections Such patients are highly infectious Hepatitis C virus (HCV) August 16, 2013 14
Slide 15-

Definitions - 5 Endotoxin concentration: Measured in endotoxin units per millilitre (EU/ml) Total viable microbial load: Expressed as colony forming units per ml (CFU/ml) August 16, 2013 15
Slide 16-

Potential Adverse Events Bacteraemia Sepsis Loss of vascular access August 16, 2013 16
Slide 17-

Modes of transmission of infection Transmission can take place through contact with: Blood or body fluids Contaminated equipment or surfaces Infected\colonised patients Staff may inadvertently spread infections from patient to patient Via direct or indirect contact with contaminated surfaces or equipment or colonised\infected patients August 16, 2013 17
Slide 18-

Diagnosing infections - 1 Signs and symptoms Systemic infection Fever, elevated white blood count (WBC), chills or rigors and\or positive blood cultures Peritonitis Abdominal pain, fever, elevated WBC, chills or rigors, cloudy effluent Culture specimens of exit site drainage and peritoneal fluid August 16, 2013 18
Slide 19-

Diagnosing infections - 2 Access site infections Redness or exudate at access site (vascular graft or PD catheter), nausea, vomiting, fatigue, and cloudy effluent in PD Exudate should be cultured August 16, 2013 19
Slide 20-

Infection Associated Risks - 1 Hepatitis B Transmitted through percutaneous or permucosal exposure to blood of infected patients HBsAg positive or HBeAg positive Blood or body fluids from positive patients can contaminate the environment Even when not visibly soiled Hepatitis B virus can remain viable at room temperature for at least 7 days August 16, 2013 20
Slide 21-

Infection Associated Risks - 2 Hepatitis B (continued) HBV has been detected on: clamps and scissors used in HD external surfaces and parts of dialysis machines Can be transmitted on gloves or unwashed hands of staff Vaccine for patients and for staff is essential component of infection prevention and control Although low incidence of HBV in many HD populations, outbreaks do occur August 16, 2013 21
Slide 22-

Infection Associated Risks - 3 Hepatitis C Transmitted primarily by percutaneous exposure to infected blood Factors increasing likelihood of HCV infection History of blood transfusions Volume of blood transfused Years on HD Inadequate IP&C practices August 16, 2013 22
Slide 23-

Infection Associated Risks - 4 Outbreaks of HCV are associated with: Receiving HD treatment immediately after an HCV infected patient Inadequately disinfected shared equipment and supplies including: Common medication carts Shared multi-dose vials Contaminated HD machines and related equipment Blood spills which were not cleaned August 16, 2013 23
Slide 24-

Infection Associated Risks - 5 Acquired Immune Deficiency Syndrome Human immunodeficiency virus is transmitted via blood or blood-containing body fluids Transmission has resulted from inadequate disinfection of equipment e.g., access needles August 16, 2013 24
Slide 25-

Infection Associated Risks - 6 Bacterial diseases Increased risk of infection and colonisation with multi-drug resistant bacteria methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) A result of Frequent health care facility contact Frequent use of antibiotics Use of invasive devices August 16, 2013 25
Slide 26-

Infection Associated Risks - 7 MRSA Outbreaks of MRSA have occurred in dialysis units Vancomycin resistant S. aureus (VRSA) reported among HD patients Other MDRO Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Acinetobacter spp. Some are resistant to all current antibiotics August 16, 2013 26
Slide 27-

Infection Associated Risks - 8 Mycobacteria Mycobacterial infections have occurred from contaminated water used for dialysis Patients with ESRD are at high risk for progression from latent tuberculosis (TB) to active TB disease. Frequent hospitalisation of dialysis patients increases risk of transmission of TB to other patients or staff August 16, 2013 27
Slide 28-

Infection Associated Risks - 9 Fungi Dialysis patients are susceptible to fungal infections such as Aspergillus spp. Strict adherence to IP&C precautions for construction and renovation critical Prompt clean up of water or other spills prevents mould contamination in environment Risk of Candida bacteraemia and peritonitis patient’s skin source August 16, 2013 28
Slide 29-

Basic IP&C Principles Dialysis surveillance program components Routine testing and documentation of HBV and HCV for chronic dialysis patients Documentation of patient’s vaccination status On-going regular and documented surveillance of bacteraemia, access site infections and peritonitis August 16, 2013 29
Slide 30-

IP&C measures - 1 Preventing access site infections and blood stream infections (BSI) Proper hand hygiene During site access: Staff must wear gloves Locate, inspect and palpate access site prior to skin preparation. Repeat if skin is touched after skin preparation and before cannulation August 16, 2013 30
Slide 31-

IP&C measures - 2 Wash access site with antibacterial soap\scrub and water HD access lines must not be used for other purposes August 16, 2013 31
Slide 32-

IP&C measures - 3 Standard and transmission-based precautions All staff must use Standard Precautions Follow Contact Precautions for multidrug resistant organisms HBsAg-positive patients and their equipment and supplies must be segregated from those from non HBV infected patients Isolation of HCV patients is not recommended August 16, 2013 32
Slide 33-

IP&C measures - 4 Environmental cleaning and disinfection Hospital grade disinfectant for all patient areas Special attention to high touch items or surfaces likely to be contaminated by blood or body fluids Procedures for containment and clean up of blood or body fluid spills Procedures to prevent mould contamination from water damage or wetting of permeable surfaces Safe disposal of used supplies and dialysers August 16, 2013 33
Slide 34-

IP&C measures - 5 Environmental cleaning and disinfection Regularly maintained, cleaned and disinfected dialysis equipment, machines and reusable supplies Policies and procedures (including care and maintenance) for dialysis systems including: Water treatment system Distribution system Dialysis machines August 16, 2013 34
Slide 35-

IP&C measures - 6 Environmental cleaning and disinfection Clean, high level disinfect, thoroughly rinse, dry and safely store safely dialysers before reuse Adequately clean dialysis machines and equipment and reusable supplies August 16, 2013 35
Slide 36-

IP&C measures - 7 Safe medication and injection practices Avoid contamination of multi-dose vials Single-use vials are preferred Disinfect stopper with alcohol before accessing Use single-use sterile needle and syringe for each access Do not recap needles Discard used sharps in designated container at point of care Use safety engineered medical devices when possible August 16, 2013 36
Slide 37-

IP&C measures - 8 Patient immunisation, post vaccine testing and screening Essential for HBV and HCV Screen for HBV prior to start of HD treatment Immunize for HBV-assess need for booster Screen for HCV prior to HD and every 6 months Pneumococcal vaccine: < 65 years of age dose every 5 years > 65 only one dose MRSA and VRE Screen only during outbreaks or suspected transmission August 16, 2013 37
Slide 38-

IP&C measures - 9 Patient and staff education Staff - initial and ongoing Principles and practices of dialysis Infectious risks Potential adverse events IP&C practices Patient Access site and dressing care Signs and symptoms of infection Importance of reporting potential infections August 16, 2013 38
Slide 39-

IP&C measures - 10 Occupational safety considerations Staff must follow Standard precautions Transmission-based precautions (as necessary) Gloves, mask and gowns for connecting and disconnecting HD Staff receive HBV vaccination and assess need for booster Routine testing of staff for HCV, HBV or MDRO is not recommended August 16, 2013 39
Slide 40-

IP&C measures - 11 Water treatment and testing Perform testing of dialysis water and dialysate at least monthly USA Association for the Advance of Medical Instrumentation guidelines Dialysis water standards: <200 CFU/ml viable microbial count <2 EU/ml endotoxin concentration If viable microbial count reaches 50 CFU/ml or endotoxin concentration reaches 1 EU/ml, take immediate corrective action Policies and procedures in place for testing and follow-up August 16, 2013 40
Slide 41-

Low resource issues Main priorities Safe reprocessing and reuse of dialysers Use, maintenance, and testing of safe reliable water supply Spatial separation for patients with HBV, MDRO and their supplies Access to reliable methods for cleaning and disinfection of supplies and equipment Access to lab testing for patients for HBV\HCV and detection of other infections Access to HBV vaccine for patients and staff August 16, 2013 41
Slide 42-

Relevant guidelines Kidney Disease Outcomes Quality Initiative (KDOQI) http://www.kidney.org/professionals/KDOQI/guidelines.cfm International Society for Peritoneal Dialysis (ISPD) Guidelines/Recommendations http://ispd.org/lang-en/treatmentguidelines/guidelines Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of European Renal Best Practice (ERBP). NDT Plus 2010; 3: 234-246. http://ckj.oxfordjournals.org/content/3/3/234.full.pdf+html?sid=8f1004ea-555c-41c1-a9d7-a83a8b3630fb August 16, 2013 42
Slide 43-

Quiz HBsAg positive patient has to be dialysed on a separate dialysis machine. T/F Prevention of access site infection includes Proper hand hygiene Staff must wear gloves Patient must wear mask a+b a+b+c For environmental cleaning and disinfection home grade disinfectant should be used for all patient areas. T/F August 16, 2013 43